Evidence map›Paper›PMID 33820985›Full record

ArticleNature metabolism2020

Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission.

Stephan Sachs, Aimée Bastidas-Ponce, Sophie Tritschler, Mostafa Bakhti, Anika Böttcher, Miguel A Sánchez-Garrido, Marta Tarquis-Medina, Maximilian Kleinert, Katrin Fischer, Sigrid Jall and 17 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Stephan Sachs *Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Aimée Bastidas-Ponce *Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Sophie Tritschler *Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Mostafa BakhtiInstitute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-2307-1122
Anika BöttcherInstitute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Miguel A Sánchez-GarridoInstitute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Marta Tarquis-MedinaInstitute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Maximilian KleinertInstitute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Katrin FischerInstitute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Sigrid JallInstitute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Alexandra HargerInstitute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Erik BaderInstitute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Sara RoscioniInstitute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
Siegfried UssarGerman Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0000-0001-7575-0920
Annette FeuchtingerResearch Unit Analytical Pathology, Helmholtz Center Munich, Neuherberg, Germany.
Burcak YesildagInSphero AG, Schlieren, Switzerland.
Aparna NeelakandhanInSphero AG, Schlieren, Switzerland.
Christine B JensenGlobal Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Marion CornuGlobal Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Bin YangNovo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
Brian FinanNovo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0002-6467-0447
Richard D DiMarchiNovo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
Matthias H TschöpInstitute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-4744-371X
Fabian J TheisInstitute of Computational Biology, Helmholtz Center Munich, Neuherberg, Germany. fabian.theis@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-2419-1943
Susanna M HofmannInstitute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. susanna.hofmann@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0001-7682-5840
Timo D MüllerInstitute of Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-0624-9339
Heiko LickertInstitute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany. heiko.lickert@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0002-4597-8825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33820985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.